amikacin has been researched along with Hodgkin Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheze, S; De Puyfontaine, O; Leporrier, M; Macro, M; Pan, B; Reman, O; Toudic, F | 1 |
Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Talavera, A | 1 |
Curtis, JE; Feld, R; Hasselback, R; Messner, HA; Tuffnell, PG | 1 |
1 trial(s) available for amikacin and Hodgkin Disease
Article | Year |
---|---|
Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Antineoplastic Agents; Ceftazidime; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Mycoses; Prospective Studies; Superinfection | 1996 |
2 other study(ies) available for amikacin and Hodgkin Disease
Article | Year |
---|---|
[Concomitant pulmonary nocardiosis and Hodgkin's disease: importance of long-term treatment].
Topics: Adult; Amikacin; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Erythromycin; Hodgkin Disease; Humans; Imipenem; Long-Term Care; Lung Diseases; Male; Minocycline; Nocardia Infections | 2002 |
Empiric therapy for infections in granulocytopenic cancer patients: continuous infusion of amikacin plus cephalothin.
Topics: Acute Disease; Amikacin; Bacterial Infections; Cephalothin; Drug Therapy, Combination; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Hodgkin Disease; Humans; Infusions, Parenteral; Kanamycin; Leukemia | 1979 |